FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W318497777> ?p ?o ?g. }

• W318497777 endingPage "4228" @default.
• W318497777 startingPage "4221" @default.
• W318497777 abstract "Research Article1 November 1993free access Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. M. Müller M. Müller Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author C. Laxton C. Laxton Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author J. Briscoe J. Briscoe Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author C. Schindler C. Schindler Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author T. Improta T. Improta Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author J.E. Darnell Jr J.E. Darnell Jr Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author G.R. Stark G.R. Stark Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author I.M. Kerr I.M. Kerr Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author M. Müller M. Müller Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author C. Laxton C. Laxton Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author J. Briscoe J. Briscoe Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author C. Schindler C. Schindler Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author T. Improta T. Improta Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author J.E. Darnell Jr J.E. Darnell Jr Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author G.R. Stark G.R. Stark Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author I.M. Kerr I.M. Kerr Imperial Cancer Research Fund Laboratories, London, UK. Search for more papers by this author Author Information M. Müller1, C. Laxton1, J. Briscoe1, C. Schindler1, T. Improta1, J.E. Darnell1, G.R. Stark1 and I.M. Kerr1 1Imperial Cancer Research Fund Laboratories, London, UK. The EMBO Journal (1993)12:4221-4228https://doi.org/10.1002/j.1460-2075.1993.tb06106.x PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Mutants in complementation group U3, completely defective in the response of all genes tested to interferons (IFNs) alpha and gamma, do not express the 91 and 84 kDa polypeptide components of interferon-stimulated gene factor 3 (ISGF3), a transcription factor known to play a primary role in the IFN-alpha response pathway. The 91 and 84 kDa polypeptides are products of a single gene. They result from differential splicing and differ only in a 38 amino acid extension at the C-terminus of the 91 kDa polypeptide. Complementation of U3 mutants with cDNA constructs expressing the 91 kDa product at levels comparable to those observed in induced wild-type cells completely restored the response to both IFN-alpha and -gamma and the ability to form ISGF3. Complementation with the 84 kDa component similarly restored the ability to form ISGF3 and, albeit to a lower level, the IFN-alpha response of all genes tested so far. It failed, however, to restore the IFN-gamma response of any gene analysed. The precise nature of the DNA motifs and combination of factors required for the transcriptional response of all genes inducible by IFN-alpha and -gamma remains to be established. The results presented here, however, emphasize the apparent general requirement of the 91 kDa polypeptide in the primary transcriptional response to both types of IFN. Previous ArticleNext Article Volume 12Issue 111 November 1993In this issue RelatedDetailsLoading ..." @default.
• W318497777 created "2016-06-24" @default.
• W318497777 creator A5017570516 @default.
• W318497777 creator A5019391436 @default.
• W318497777 creator A5027018113 @default.
• W318497777 creator A5029776635 @default.
• W318497777 creator A5082129559 @default.
• W318497777 creator A5082272824 @default.
• W318497777 creator A5087032740 @default.
• W318497777 creator A5090427988 @default.
• W318497777 date "1993-11-01" @default.
• W318497777 modified "2023-10-14" @default.
• W318497777 title "Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways." @default.
• W318497777 cites W142141927 @default.
• W318497777 cites W1540303400 @default.
• W318497777 cites W1584086642 @default.
• W318497777 cites W1625377704 @default.
• W318497777 cites W178836386 @default.
• W318497777 cites W1847235528 @default.
• W318497777 cites W1851636512 @default.
• W318497777 cites W1861818061 @default.
• W318497777 cites W1866683333 @default.
• W318497777 cites W1912856651 @default.
• W318497777 cites W1965398762 @default.
• W318497777 cites W1967821126 @default.
• W318497777 cites W1969979508 @default.
• W318497777 cites W1983630074 @default.
• W318497777 cites W1985303436 @default.
• W318497777 cites W1986021037 @default.
• W318497777 cites W1990474286 @default.
• W318497777 cites W1991111624 @default.
• W318497777 cites W1993292631 @default.
• W318497777 cites W2009337117 @default.
• W318497777 cites W2009968835 @default.
• W318497777 cites W2012588545 @default.
• W318497777 cites W2018289835 @default.
• W318497777 cites W2022167790 @default.
• W318497777 cites W2036576687 @default.
• W318497777 cites W2037310569 @default.
• W318497777 cites W2042326065 @default.
• W318497777 cites W2053944590 @default.
• W318497777 cites W2055555788 @default.
• W318497777 cites W2067626539 @default.
• W318497777 cites W2074514239 @default.
• W318497777 cites W207455869 @default.
• W318497777 cites W2078119356 @default.
• W318497777 cites W2084590985 @default.
• W318497777 cites W2093874299 @default.
• W318497777 cites W2097942910 @default.
• W318497777 cites W2099340972 @default.
• W318497777 cites W2100837269 @default.
• W318497777 cites W2109389988 @default.
• W318497777 cites W211546640 @default.
• W318497777 cites W2116387633 @default.
• W318497777 cites W2122312331 @default.
• W318497777 cites W2136098448 @default.
• W318497777 cites W2136690547 @default.
• W318497777 cites W2150317970 @default.
• W318497777 cites W2153987432 @default.
• W318497777 cites W2161239928 @default.
• W318497777 cites W2171759277 @default.
• W318497777 cites W2177943720 @default.
• W318497777 cites W2238786398 @default.
• W318497777 cites W2252225016 @default.
• W318497777 cites W2284895064 @default.
• W318497777 cites W2576734941 @default.
• W318497777 cites W275894516 @default.
• W318497777 cites W344789099 @default.
• W318497777 doi "https://doi.org/10.1002/j.1460-2075.1993.tb06106.x" @default.
• W318497777 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/413716" @default.
• W318497777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7693454" @default.
• W318497777 hasPublicationYear "1993" @default.
• W318497777 type Work @default.
• W318497777 sameAs 318497777 @default.
• W318497777 citedByCount "403" @default.
• W318497777 countsByYear W3184977772012 @default.
• W318497777 countsByYear W3184977772013 @default.
• W318497777 countsByYear W3184977772014 @default.
• W318497777 countsByYear W3184977772015 @default.
• W318497777 countsByYear W3184977772016 @default.
• W318497777 countsByYear W3184977772017 @default.
• W318497777 countsByYear W3184977772018 @default.
• W318497777 countsByYear W3184977772019 @default.
• W318497777 countsByYear W3184977772020 @default.
• W318497777 countsByYear W3184977772021 @default.
• W318497777 countsByYear W3184977772022 @default.
• W318497777 countsByYear W3184977772023 @default.
• W318497777 crossrefType "journal-article" @default.
• W318497777 hasAuthorship W318497777A5017570516 @default.
• W318497777 hasAuthorship W318497777A5019391436 @default.
• W318497777 hasAuthorship W318497777A5027018113 @default.
• W318497777 hasAuthorship W318497777A5029776635 @default.
• W318497777 hasAuthorship W318497777A5082129559 @default.
• W318497777 hasAuthorship W318497777A5082272824 @default.
• W318497777 hasAuthorship W318497777A5087032740 @default.
• W318497777 hasAuthorship W318497777A5090427988 @default.
• W318497777 hasBestOaLocation W3184977771 @default.
• W318497777 hasConcept C104317684 @default.

• next